Ulka Vaishampayan
@DrVaishampayan
Followers
1K
Following
597
Media
15
Statuses
715
I'm trendy fun loving but serious and hard working.
Ann arbor MI
Joined June 2009
@tompowles1 Support SWOG 1931 PROBE trial. Delayed nephrectomy has a potential role to improve outcomes in management of synchronous met RCC
2
3
10
Comprehensive overview and remarkable presented
In the final session of @ASCO #GU23, @markballmd @NIH cites the diverse outcomes across series with surgery for #kidneycancer following IO. Terrific, comprehensive overview. Ultimately an answer will hopefully come from @SWOG #PROBE, led by @DrVaishampayan & @HyungLKim!
1
0
5
Lots of folks up bright & early to discuss @theNCI trials from @SWOG, @eaonc, @NRGonc & @ALLIANCE_org ahead of sessions at @ASCO #GU23! @TiansterZhang @utswcancer kicks off the mtg w discussion of #PDIGREE, brilliant study led by her & @DrChoueiri @DanaFarber. Next up: #PROBE!
1
8
47
Let’s come together to tackle the RCC problem
@TiansterZhang @PBarataMD @BradMcG04 @DrVaishampayan @DrRanaMcKay @maughanonc @DrChoueiri @montypal @KidneyCancerDoc @SuzanneColeMD @PrimoLaraMD @neerajaiims @apolo_andrea @bergsa83 @alantanmd Excellent organization @TiansterZhang @SuzanneColeMD @DrVaishampayan to review and promote NCTN RCC studies
0
0
5
Exciting molecular data from CTC profiling collaboration between Datar Genetics and @UMRogelCancer
0
0
4
touting S1931 PROBE trial in met RCC. Hope u can join and support this unique study exploring role of cytoreductive nephrectomy in the setting of immune therapy. @Huntsman_GU @ASCO @wandering_gu @PGrivasMDPhD @montypal
0
0
1
#NCTN #clincialtrials in renal cell carcinoma investigator meeting at #GU23: Feb. 18, 9 am ET/6 am PT Twin Peaks Room, or join via Zoom from https://t.co/XWdGjxrHnE. Trials include PAPMET2 (S2200) and PROBE (S1931).
0
0
2
#NCTN #clincialtrials in renal cell carcinoma investigator meeting at #GU23: Feb. 18, 9 am ET/6 am PT Twin Peaks Room, or join via Zoom from https://t.co/XWdGjxrHnE. Trials include PAPMET2 (S2200) and PROBE (S1931).
1
5
8
touting S1931 PROBE trial in met RCC. Hope u can join and support this unique study exploring role of cytoreductive nephrectomy in the setting of immune therapy. @Huntsman_GU @ASCO @wandering_gu @PGrivasMDPhD @montypal
0
5
12
Please attend tomorrow sat at 6 am pacific time
This Saturday, 2/18, 6 am PST - NCTN Trials in Renal Cell Carcinoma Investigator Meeting! Learn more about #PDIGREE #PROBE #RADICAL #SAMURAI #PAPMET2 trials! #ASCO @ALLIANCE_org @SWOG @NRGOncology @eaonc .@DrRanaMcKay .@DrVaishampayan .@maughanonc .@whallradonc .@TiansterZhang
0
0
1
Exciting results!
Abs#603 @ASCO #GU23 by @BurottoMauricio 👉 https://t.co/dpsfGxPjek Checkmate-9ER ph3 mRCC #kidneycancer update 👉 Nivo+Cabozantinib vs Sunitinib: median OS is 49.5 vs 29.2 mos in int/poor risk pts, ORR👇 @DrChoueiri @tompowles1 @OncoAlert @urotoday @Uromigos @KidneyCancer
0
0
3
Looking forward to MSHO first Precision medicine symposium
0
0
4
Please join us and review all co op group RCC trials. We r in this together fighting RCC. @UMRogelCancer @SWOG @SupportingSWOG @kcCURE @IKCCorg
Terrific opportunity to showcase the strenghths of the cooperative group! Please attend if you are heading to @ASCO GU!
0
2
9
Terrific opportunity to showcase the strenghths of the cooperative group! Please attend if you are heading to @ASCO GU!
Calling all #NCTN #kidneycancer trial PIs! Come join us at #NCTN investigator meeting discussing #PDIGREE #PROBE #RADICAL #SAMURAI #PAPMET2 trials! ✅ Sat 2/18 6am @ICSF twin peaks @ALLIANCE_org @SWOG @NRGonc @eaonc
@DrRanaMcKay @DrVaishampayan @maughanonc @whallradonc #GU23
0
5
19
Impressive work@vitalyMargulis
Packed room to hear #VitalyMargulis talk about “real cancer” — #kidneycancer with IVC thrombus. Important patient selection, careful attention & collaboration w CT surgeons, & perioperative systemic treatments — he leads a trial now open @utswcancer @UTSWUrology for IVC thrombus!
0
1
4
U remain inspiring and amazing
Pleased to share my scans came back with good news. May makes 7 years since my #stage4 #kidneycancer diagnosis. I’ll be spending my cancerversary at SWOG’s spring meeting. The irony isn’t lost on me & feels very fitting. I never take good scans for granted. I know how lucky I am.
1
0
5
A way to the future!@Dr_R_Kurzrock
Precision Medicine World Congress I am walking the hallways through the precision medicine world congress and I feel like I traveled from another galaxy and found my home planet. Everywhere are the words precision medicine, personalized medicine, patient care, multi-omics
0
0
2
Amazing translational study design.
7/9 Eligibility includes men w/CRPC w/at least 1 copy of the adrenal-permissive HSD3B1 allele (more active biosynthesis > more likely to benefit). Men get the BMX inhibitor abivertinib + abiraterone. Will have abi-naïve & –progressing cohorts. 9 sites will participate! @ThePCCTC
1
0
0
Patient communication is critical and we share a video to help consider this critical study in metastatic kidney cancer. @UMRogelCancer @TiansterZhang @neerajaiims @HyungLKim @montypal @ShuchiGulati @KidneyCancerDoc @kcCURE @DrRanaMcKay @DrChoueiri @alantanmd
A new video has been posted introducing patients to the @SWOG S1931 trial in #kidneycancer: Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer @DrVaishampayan
https://t.co/C2pbs2epbs
0
10
22
A new video has been posted introducing patients to the @SWOG S1931 trial in #kidneycancer: Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer @DrVaishampayan
https://t.co/C2pbs2epbs
0
5
7